| A case of central diabetes insipidus that was caused by pituitary metastasis of lung adenocarcinoma and was controlled by radiation therapy Y Izumi, T Masuda, S Nabeshima, Y Horimasu, T Nakashima, S Miyamoto, ... Gan to Kagaku ryoho. Cancer & Chemotherapy 44 (6), 513-516, 2017 | 9 | 2017 |
| A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia: A proof-of-concept study Y Horimasu, S Ohshimo, K Yamaguchi, S Sakamoto, T Masuda, ... Medicine 100 (7), e24738, 2021 | 20 | 2021 |
| A retrospective study comparing pemetrexed with taxanes as front-line cytotoxic chemotherapy for lung adenocarcinoma K Yamaguchi, K Miwata, Y Horimasu, T Masuda, T Nakashima, ... Annals of Oncology 26, vii123, 2015 | | 2015 |
| A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline M Fioravanti, T Nakashima, J Xu, A Garg BMJ open 4 (7), e005090, 2014 | 52 | 2014 |
| A41 INTERSTITIAL LUNG DISEASE: RISK FACTORS AND OUTCOMES: Annual Decline In Lung Function Can Predict The Prognosis Of Patients With Chronic Hypersensitivity Pneumonia Y Horimasu, N Ishikawa, T Nakashima, H Iwamoto, T Senoo, S Ohshimo, ... American Journal of Respiratory and Critical Care Medicine 189, 1, 2014 | | 2014 |
| A80-C MOLECULAR AND IMMUNOBIOLOGY OF LUNG CANCER: Pai-1 Plays An Important Role In Lung Cancer Progression Through Differentiation Of Cancer-Associated Fibroblasts To … T Masuda, N Hattori, Y Horimasu, S Miyamoto, T Nakashima, H Iwamoto, ... American Journal of Respiratory and Critical Care Medicine 193, 1, 2016 | | 2016 |
| Accelerated decline in lung function in adults with a history of remitted childhood asthma S Miura, H Iwamoto, K Omori, K Yamaguchi, S Sakamoto, Y Horimasu, ... European Respiratory Journal 59 (1), 2022 | 12 | 2022 |
| Additional octreotide therapy to sirolimus achieved a decrease in sirolimus-refractory chylous effusion complicated with lymphangioleiomyomatosis M Namba, T Masuda, T Nakamura, Y Horimasu, S Miyamoto, ... Internal Medicine 56 (24), 3327-3331, 2017 | 3 | 2017 |
| AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma K Yamaguchi, H Iwamoto, S Sakamoto, Y Horimasu, T Masuda, ... Oncotarget 8 (55), 94382, 2017 | 11 | 2017 |
| Airway reversibility assessed by oscillometry in patients with asthma N Higaki, H Iwamoto, Y Horimasu, T Masuda, S Miyamoto, T Nakashima, ... European Respiratory Journal 50 (suppl 61), 2017 | | 2017 |
| Albumin–globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer Y Nakanishi, T Masuda, K Yamaguchi, S Sakamoto, Y Horimasu, T Mimae, ... International Journal of Clinical Oncology 25, 74-81, 2020 | 26 | 2020 |
| Alectinib-induced immune hemolytic anemia in a patient with lung adenocarcinoma J Okumoto, S Sakamoto, T Masuda, K Yamaguchi, Y Horimasu, ... Internal Medicine 60 (4), 611-615, 2021 | 9 | 2021 |
| Alternate‑day administration of S‑1 for elderly patients with advanced non‑small‑cell lung carcinoma: A prospective feasibility study T Masuda, M Watanabe, K Fujitaka, K Hamai, N Ishikawa, S Kitaguchi, ... Molecular and Clinical Oncology 9 (5), 539-544, 2018 | 4 | 2018 |
| Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma T Otsuki, T Nakashima, H Hamada, Y Takayama, S Akita, T Masuda, ... European Respiratory Journal 51 (5), 2018 | 20 | 2018 |
| Analysis of microRNA expression in liquid-based cytology samples may be useful for primary lung cancer diagnosis Y Araki, K Arihiro, K Yamaguchi, S Sakamoto, Y Horimasu, T Masuda, ... American Journal of Clinical Pathology 156 (4), 644-652, 2021 | 3 | 2021 |
| Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Y Horimasu, N Ishikawa, T Nakashima, H Iwamoto, T Senoo, S Ohshimo, ... European Respiratory Journal 44 (Suppl 58), 2014 | | 2014 |
| Annual Decline In Lung Function Can Predict The Prognosis Of Patients With Chronic Hypersensitivity Pneumonia Y Horimasu, N Ishikawa, T Nakashima, H Iwamoto, T Senoo, S Ohshimo, ... A41. INTERSTITIAL LUNG DISEASE: RISK FACTORS AND OUTCOMES, A1488-A1488, 2014 | | 2014 |
| Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1 M Namba, N Hattori, H Hamada, K Yamaguchi, Y Okamoto, T Nakashima, ... Cancer letters 442, 31-39, 2019 | 19 | 2019 |
| Anti-Tumor Effect Of MT95-4, A Fully Humanized Anti-Aminopeptidase N Monoclonal Antibody, On Tumor Progression In An Animal Model Of Malignant Pleural Mesothelioma T Otsuki, N Hattori, H Hamada, Y Takayama, Y Horimasu, T Masuda, ... C110. MESOTHELIOMA AND MALIGNANT PLEURAL DISEASE: FROM BENCH TO BEDSIDE TO …, 2016 | | 2016 |
| Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity H Takahashi, T Nakashima, T Masuda, M Namba, S Sakamoto, ... Stem Cell Research & Therapy 12, 1-14, 2021 | 6 | 2021 |
Manabu AbeProfessor of Chemistry, Hiroshima University在 hiroshima-u.ac.jp 的电子邮件经过验证
Manabu AbeProfessor of Chemistry, Hiroshima University在 hiroshima-u.ac.jp 的电子邮件经过验证
Hideyuki OguroUniversity of Connecticut School of Medicine在 uchc.edu 的电子邮件经过验证